UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
11.55
+0.10 (0.87%)
Nov 21, 2024, 4:00 PM EST - Market closed

UroGen Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
487463205213398700
Upgrade
Market Cap Growth
23.92%126.06%-3.94%-46.44%-43.13%0.97%
Upgrade
Enterprise Value
352409184105276481
Upgrade
Last Close Price
11.4515.008.879.5118.0233.37
Upgrade
PS Ratio
4.795.603.184.4433.7438893.81
Upgrade
PB Ratio
18.93-7.10-2.2925.344.133.88
Upgrade
P/TBV Ratio
20.96--25.344.133.88
Upgrade
EV/Sales Ratio
3.944.952.852.1823.3626736.92
Upgrade
Debt / Equity Ratio
4.81-1.54-1.120.180.030.02
Upgrade
Asset Turnover
0.360.530.500.400.070.00
Upgrade
Inventory Turnover
1.381.871.671.52--
Upgrade
Quick Ratio
8.314.884.714.515.097.55
Upgrade
Current Ratio
9.005.425.395.115.397.63
Upgrade
Return on Equity (ROE)
----211.55%-92.88%-77.77%
Upgrade
Return on Assets (ROA)
-21.12%-26.09%-38.69%-47.72%-46.29%-44.73%
Upgrade
Return on Capital (ROIC)
-50.64%-179.24%-479.55%-105.88%-52.96%-49.84%
Upgrade
Earnings Yield
-23.35%-22.08%-53.60%-51.98%-32.27%-15.02%
Upgrade
FCF Yield
-19.50%-16.54%-42.88%-40.17%-26.90%-10.19%
Upgrade
Buyback Yield / Dilution
-46.48%-26.43%-2.06%-2.60%-6.10%-30.31%
Upgrade
Total Shareholder Return
-46.48%-26.43%-2.06%-2.60%-6.10%-30.31%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.